The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories. The global recombinant protein market size is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 11.5% from 2023 to 2030. The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Recombinant Protein Market by Segment
The study includes trends and forecast for the global recombinant protein market by product type, expression system, application, end use industry, and region, as follows:
Recombinant Proteins Market
Recombinant Protein Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2030]:
AntibodiesAntigensEnzymesHormonesOthersRecombinant Protein Market by Expression System [Value ($B) Shipment Analysis from 2017 to 2030]:
MicrobesPlantsAnimalsRecombinant Protein Market by Application [Value ($B) Shipment Analysis from 2017 to 2030]:
Drug Discovery and DevelopmentResearch ApplicationTherapeutic UseDiagnosticsOthersRecombinant Protein Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2030]:
Biotechnology and Pharmaceutical CompaniesAcademic and Research InstitutesContract Research OrganizationsOthersRecombinant Protein Market by Region [Value ($B) Shipment Analysis from 2017 to 2030]:
North AmericaEuropeAsia PacificThe Rest of the WorldList of Recombinant Protein Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, recombinant protein companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the recombinant protein companies profiled in this report include-
AbcamSino BiologicalR&D SystemsGenScriptBio-Rad LaboratoriesRecombinant Protein Market Insights
The analyst forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.
Pharma & biotechnology companies are expected to remain the largest end use industry segment due to the increasing the demand for recombinant proteins in drug research for prediction, prognosis, and diagnosis.
North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Features of the Recombinant Protein Market
Market Size Estimates: Recombinant protein market size estimation in terms of value ($B)Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2030) by various segments and regions.Segmentation Analysis: Recombinant protein market size by various segments, such as product type, expression system, application, end use industry, and regionRegional Analysis: Recombinant protein market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.Growth Opportunities: Analysis on growth opportunities in different product types, expression systems, applications, end use industries, and regions for the recombinant protein market.Strategic Analysis: This includes M&A, new product development, and competitive landscape for the recombinant protein market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.Continue…
About The Vertex Business Insights
With a deep understanding of the industry landscape, Vertex Business Insights is a research and advisory firm offering insights into a variety of industry verticals, products, and services. Our team of highly experienced professionals offers a holistic and research-driven view of every industry vertical, product or service, or industry sector. Our aim is to help our clients make informed decisions and stay ahead of the competition. We offer highly informative research reports as well as corporate-ready advisory and consulting services. The insights we provide can help organizations achieve their business goals in an accurate and actionable way.
CONTACT US
Phone:
+ (210) 775-2636 (USA)
+ (91) 853 060 7487
Sign in to leave a comment.